Author(s): Kirov II, Tal A, Babb JS, Herbert J, Gonen O
Objective:To characterize and follow the diffuse gray and white matter (GM/WM) metabolic abnormalities in early relapsing-remitting multiple sclerosis using proton magnetic resonance spectroscopic imaging ((1)H-MRSI).
Methods:Eighteen recently diagnosed, mildly disabled patients (mean baseline time from diagnosis 32 months, mean Expanded Disability Status Scale [EDSS] score 1.3), all on immunomodulatory medication, were scanned semiannually for 3 years with T1-weighted and T2-weighted MRI and 3D (1)H-MRSI at 3 T. Ten sex- and age-matched controls were followed annually. Global absolute concentrations of N-acetylaspartate (NAA), choline (Cho), creatine (Cr), and myo-inositol (mI) were obtained for all GM and WM in the 360 cm(3) (1)H-MRSI volume of interest.
Results:Patients' average WM Cr, Cho, and mI concentrations (over all time points), 5.3 ± 0.4, 1.6 ± 0.1, and 5.1 ± 0.7 mM, were 8%, 12%, and 11% higher than controls' (p ≤ 0.01), while their WM NAA, 7.4 ± 0.7 mM, was 6% lower (p = 0.07). There were increases with time of patients' WM Cr: 0.1 mM/year, Cho: 0.02 mM/year, and NAA: 0.1 mM/year (all p < 0.05). None of the patients' metabolic concentrations correlated with their EDSS score, relapse rate, GM/WM/CSF fractions, or lesion volume.
Conclusions:Diffuse WM glial abnormalities were larger in magnitude than the axonal abnormalities and increased over time independently of conventional clinical or imaging metrics and despite immunomodulatory treatment. In contrast, the axonal abnormalities showed partial recovery, suggesting that patients' lower WM NAA levels represented a dysfunction, which may abate with treatment. Absence of detectable diffuse changes in GM suggests that injury there is minimal, focal, or heterogeneous between cortex and deep GM nuclei.
Referred From: https://pubmed.ncbi.nlm.nih.gov/23175732/
Author(s): Tomassini V, Matthews PM, Thompson AJ, Fuglø D, Geurts JJ, et al.
Author(s): Genova HM, Hillary FG, Wylie G, Rypma B, Deluca J
Author(s): Chiaravalloti N, Hillary F, Ricker J, Christodoulou C, Kalnin A, et al.
Author(s): Sumowski JF, Wylie GR, Leavitt VM, Chiaravalloti ND, Deluca J
Author(s): Pantano P, Iannetti GD, Caramia F, Mainero C, Di Legge S, et al.
Author(s): Hillary FG, Chiaravalloti N, Ricker JH, Steffener J, Bly BM, et al.
Author(s): Pantano P, Mainero C, Iannetti GD, Caramia F, Di Legge S, et al.
Author(s): Staffen W, Zauner H, Mair A, Kutzelnigg A, Kapeller P, et al.
Author(s): Kirov II, Patil V, Babb JS, Rusenek H, Herbert J, et al.
Author(s): Sajja BR, Wolinsky JS, Narayana PA
Author(s): De Stefano N, Filippi M, Miller D, Pouwels PJ, Rovira a, et al.
Author(s): Llufriu S, Kornak J, Ratiney H, Oh J, Brenneman D, et al.
Author(s): Lee M, Reddy H, Johansen-Berg H, Pendlebury S, Jenkinson M, et al.
Author(s): Mainero C, Caramia F, Pozzilli C, Pisani A, Pestalozza I, et al.
Author(s): Reddy H, Narayanan S, Woolrich M, Mitsumori T, Arnold DL, et al.
Author(s): Reddy H, Narayanan S, Arnoutelis R, Jenkinson M, Antel J, et al.
Author(s): Van Schependom J, D’hooghe MB, Cleynhens K, D’hooge M, Haelewyck M-C, et al.
Author(s): Reddy H, Narayanan S, Matthews PM, Hoge RD, Pike GB, et al.
Author(s): Inglese M, Li BSY, Rusinek H, Babb JS, Grossman RI, et al.
Author(s): McDonald WI, Compston a, Edan G, Goodkin D, Hartung HP, et al.
Author(s): Ashburner J, Neelin P, Collins DL, Evans A, Friston K
Author(s): Cox RW
Author(s): Gonen O, Murdoch JB, Stoyanova R, Goelman G
Author(s): Soher BJ, Young K, Govindaraju V, Maudsley AA
Author(s): Lynch J, Peeling J, Auty A, Sutherland GR
Author(s): Mikheev A, Nevsky G, Govindan S, Grossman R, Rusinek H
Author(s): Sled JG, Zijdenbos AP, Evans AC
Author(s): Kirov II, Patil V, Babb JS, Rusinek H, Herbert J, et al.
Author(s): Li BS, Wang H, Gonen O